Keep up to date with the latest news and views from the brachytherapy experts


The information in these interviews is provided by medical professionals, sharing their views on brachytherapy, and they do not necessarily reflect the view of Elekta. The information is not peer reviewed and should not be used to draw scientific medical conclusions or to base treatment decisions upon.

Christian Kirisits, Medical University of Vienna/Vienna General Hospital: 'Views on Brachytherapy'

Pedro Lara, Hospital Universitario de Gran Canaria Dr. Negrin: 'Reflexiones sobre la Braquiterapia' (in Spanish language)

Yaw Chin, St. George Hospital Cancer Care Centre: 'Views on Brachytherapy'

Vratislav Strnad, University Hospital Erlangen: 'Views on Brachytherapy'

Ferran Guedea, Catalan Institute of Oncology: 'Views on Brachytherapy'

Janusz Skowronek, Greater Poland Cancer Center: Journal of Contemporary Brachytherapy

György Kovács, University Medical Center Schleswig-Holstein: 'The advantages and the future of brachytherapy’

Kari Tanderup, Aarhus University Hospital: ‘Research and developments in brachy physics’

Luc Beaulieu, Cancer Research Centre, Université Laval: ‘Next generation brachy physics’

Picture prof Nakano

Takashi Nakano, Gunma University:‘Benefits of Brachytherapy and more’

Marjory Jolicoeur, Charles-Lemoyne Hospital:‘Brachy education at Charles-Lemoyne Hospital’

Dr. Alexandra Stewart, Royal Surrey County Hospital: ‘Benefits of brachytherapy’

Prof. Itami, National Cancer Centre Hospital:'Brachytherapy in Japan'

Dave Gaffney Utah – Huntsman Cancer Institute and South Jordan Health Center: ‘Brachytherapy: perspective of an ABS President’

Umesh Mahantshetty – Tata Memorial Hospital: ‘Brachytherapy in India’

Henrike Westerveld and Bradley Pieters - Academic Medical Center: ‘Amsterdam Brachy College’

Robert Kuske, Arizona Breast Cancer Specialists: 'Brachy APBI - PROMIS study'

Linda Smith, Comprehensive Breast Care Albuquerque: 'Brachy APBI: surgeon's perspective'

Johann Tang, National University Cancer Institute / National University Hospital Singapore: 'Brachy APBI in Singapore'

Atif Khan, Rutgers Cancer Institute of New Jersey: 'Brachy APBI and 2-day study'

Vratislav Strnad, University Hospital Erlangen: 'Level 1 evidence for brachy APBI

Micth Kamrava, UCLA Jonsson Comprehensive Cancer Center: 'Brachy APBI – PROMIS study’

Csaba Polgar, National Institute of Oncology Budapest:'Excellent cosmesis after brachy APBI’

Chirag Shah - Rutgers University: ‘Accelerated Partial Breast Irradiation’

Dr. Cristina Gutièrrez - Catalan Institute of Oncology: ‘APBI and the advantages of Brachytherapy’

Dr. R. Kuske - Arizona Breast Cancer Specialists - ‘Triumph-T breast brachytherapy study’

Sushil Beriwal, University of Pittsburgh School of Medicine - Cervical cancer brachytherapy studies

Beant Gill, University of Pittsburgh Cancer Institute: 'Endometrial cancer brachytherapy studies'

Matthew Biagioli, Florida Hospital: 'Importance of brachytherapy for cervix'

Professor Richard Pötter, Medical University Vienna/General Hospital Vienna:‘IGABT - development and future’

Andrew Orton – Huntsman Cancer Institute: ‘Brachytherapy in vaginal Cancer’

Dr Anuja Jhingran - MD Anderson: ‘The differences in availability and usage of Brachytherapy in cervical cancer in the US vs the developing world’

Dr. Spencer Thompson - Stephenson Cancer Center: ‘Brachytherapy, an essential treatment for curing cervical cancer’

Dr. Rachit Kumar and Dr. Amir Sadeghi: HDR brachytherapy for prostate cancer at Banner MD Anderson

Shafak Aluwini, Erasmus MC:‘HDR brachytherapy for prostate’

Gerard Morton - Sunnybrook Hosptial: ‘HDR and LDR brachytherapy for prostate cancer’

Yasuo Yoshioka - Osaka University Graduate School of Medicine : ‘Prostate Brachytherapy in Japan’

Dr. Dan Krauss - Beaumont Hospital: ‘Practical prostate brachytherapy’

Dr. Ann Henry - St. James Institute of Oncology: ‘Real-time image guided HDR Brachytherapy for prostate cancer’

Dr. Peter Rossi - Calaway Young Cancer Center: 'HDR prostate brachytherapy, and how it can improve efficacy and toxicity outcomes in men seeking this treatment'.

Dr. Gerard Morton - Sunnybrook Health Center:' Gerard Morton's view on HDR versus LDR in brachytherapy of the prostate.

Michael Kasper and Zoubir Ouhib, The Lynn Cancer Institute : 'HDR skin brachy: treatment and education'

Dr. Michael Kasper - Boca Raton Regional Hospital: 'has an extensive history using brachytherapy and the benefits to skin cancer patients'.

Dr. S. Corradini and Prof. J. Ricke – LMU Munich: ‘an important option for liver cancer patients’